Phase II Concurrent Proton and Chemotherapy in Locally Advanced Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC).
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2017
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 20 Jun 2017 Status changed from active, no longer recruiting to completed.
- 22 Nov 2016 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.
- 19 Nov 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Apr 2017 as per ClinicalTrials.gov record.